Proteo Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Paal Juergen Michael, was filed 18 Apr 2016.
Proteo Inc: what insiders have been doing
This page follows insider dealings at Proteo Inc as filed with SEC (Form 4). No insider at Proteo Inc has published a filing in the past twelve months. The most recent one dates from 14 December 2018.
Our records for Proteo Inc go back to 2014, with 8 purchases and no sales on the open market in total.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2019FY ended December 2019 · cache
- 1,000,000 shares@ US$0.08100.0% of flowPROTEO, INC. COMMON STOCKSEC:0001683168-18-003707:0
- 20,000 shares@ US$0.08100.0% of flowCommon StockSEC:0001627906-16-000005:0Canonical exit: 14 Jul 2016 (T+90)
- 2,500 shares@ US$0.25Common StockSEC:0001627906-15-000004:0Canonical exit: 23 Jul 2015 (T+90)
- 1,359 shares@ US$0.10Common StockSEC:0001627906-15-000003:0Canonical exit: 12 Jul 2015 (T+90)
- 2,500 shares@ US$0.10Common StockSEC:0001627906-15-000002:0Canonical exit: 8 Jul 2015 (T+90)
- 50,000 shares@ US$0.09Common StockSEC:0001627906-15-000001:0Canonical exit: 13 Apr 2015 (T+90)
- 1,110 shares@ US$0.08Common StockSEC:0001627906-14-000004:0Canonical exit: 21 Mar 2015 (T+90)
- 24,281 shares@ US$0.08Common StockSEC:0001627906-14-000003:0Canonical exit: 15 Mar 2015 (T+90)
- 14,619 shares@ US$0.08Common StockSEC:0001627906-14-000002:0Canonical exit: 8 Mar 2015 (T+90)
- 4,300,000 shares0CommonSEC:0001019687-14-000975:0
- 4,300,000 shares0CommonSEC:0001019687-14-000976:0
11 of 11 declarations
About Proteo Inc
Proteo Inc is a company listed on the XNAS market. It specializes in developing innovative solutions in the biopharmaceutical sector.
